Skip to content

Zambia Common Elements Treatment Approach Pilot Study

Zambia Common Elements Treatment Approach Pilot Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03966885
Acronym
ZCAP
Enrollment
160
Registered
2019-05-29
Start date
2019-06-24
Completion date
2020-03-17
Last updated
2022-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Use Disorder, Depression, HIV/AIDS, Post-traumatic Stress Disorder, Substance Use Disorders

Brief summary

This is a randomized controlled trial (RCT) evaluating the effectiveness of an alcohol brief intervention alone compared to the brief intervention plus an evidence-based psychotherapy (CETA) in reducing alcohol misuse and co-occurring mental health problems among persons with HIV in Zambia.

Detailed description

Alcohol misuse is a major unaddressed barrier to ending the HIV/AIDS epidemic. Hazardous drinking increases HIV transmission, delays antiretroviral therapy (ART) uptake, reduces adherence and retention, and increases mortality. Comorbid mental health or substance misuse, similar to alcohol use alone, can also significantly undermine HIV treatment. The vast majority of people living with HIV globally live in low- and middle-income countries (LMIC). Similar to most HIV care settings in LMIC, in Zambia, the location of the current study, there are no readily available evidence-based treatments for alcohol misuse or mental health problems. This study will enroll persons living with HIV (PLWH) who have alcohol misuse in Zambia. Participants will be recruited and screened during regular HIV care visits. Participants will be recruited by their regular care providers (i.e., peer educators, counselors, nurses, physicians) and referred to study staff if they are interested. The investigators anticipate enrolling up to 320 participants, all of whom have hazardous alcohol use. N=160 participants will be high-risk drinkers due to having either a moderate-to-severe alcohol use disorder or mental health comorbidities, or both. These participants will be randomized into the RCT. Participants who have hazardous alcohol use (but not a moderate-to-severe AUD) without mental health comorbidities (a lower risk group of participants) will not be enrolled into the RCT but will be tracked as part of a parallel cohort study. The minimum age of research subjects will be 18. Eligibility will be assessed via audio computer assisted self-interviewing (ACASI). Participants in the 'cohort study' (i.e., lower risk participants) will receive a brief alcohol intervention. Participants in the RCT (i.e., higher risk participants) will be randomly assigned on a 1:1 basis (stratified by gender) to receive the brief intervention alone or the brief intervention plus CETA. All participants will be evaluated for outcomes at baseline and at a six month follow-up visit. For RCT participants, the investigators will compare the effectiveness of the brief intervention alone to the brief intervention plus CETA in reducing alcohol misuse and mental health problems. For cohort participants, the investigators will collect preliminary data on whether alcohol misuse reduced at the six month follow-up but there will be no comparison/control group. The findings from this pilot study will be used to inform future programming and research in Zambia and other LMIC to implement screening, brief intervention, and referral to treatment (SBIRT) programs for alcohol use in HIV care.

Interventions

BEHAVIORALBrief Intervention

The BI used in the trial combines motivational interviewing skills with cognitive behavioral therapy elements in order to assist clients with self identified substance misuse to begin to consider changing their rates of drinking and drug use. The intervention lasts 30 to 40 minutes and consists of 5 components including: 1) screening 2) identification and information on the impacts of substance misuse 3) talking about change and goal setting 4) understanding the primary reason for drinking 5) skill building with practice and 6) referral for services.

The Common Elements Treatment Approach, or CETA, is a transdiagnostic psychotherapy based on cognitive behavioral elements for mood, anxiety and trauma related problems, and for alcohol and substance misuse. CETA is based on the fact that most evidence-based mental health treatments (EBTs) consist of similar components. The objective of CETA is to provide a single training in a range of therapy components that are similar across EBTs and to then teach counselors how to design a specific course of treatment for each client based on the client's presenting problems.

Sponsors

Centre for Infectious Disease Research in Zambia
CollaboratorOTHER
University of Alabama at Birmingham
CollaboratorOTHER
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
CollaboratorNIH
Columbia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Primary outcomes are evaluated via Audio Computer Assisted Self-Interviewing (ACASI)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Initial inclusion criteria for overall enrollment (into either the Cohort or RCT study) will be: * HIV positive * Receiving HIV treatment services at one of the two study clinics * Current hazardous alcohol use, defined as an AUDIT score of ≥8 for men and ≥ 4 for women * Provides informed consent Secondary inclusion for enrollment into the RCT will be: * AUDIT scores that indicate a moderate-to-severe AUD (≥12 for women; ≥16 among men) * AND/OR: meeting validated symptom criteria for depression (≥16 on Center for Epidemiological Studies-Depression (CES-D), trauma/anxiety (≥2.5 on HTQ), and/or substance use (≥27 for any non-tobacco/alcohol substance on ASSIST)

Exclusion criteria

* HIV negative * Not receiving care at one of the study clinics * Currently psychotic or actively suicidal * Unable to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Change in Alcohol Use Disorders Identification Test (AUDIT) Scale Score From Baseline to 6-month Post-baseline.Baseline and 6 months post-baselineAUDIT is a 10-item measure of hazardous alcohol use with possible range of 0-40 (total scale score). Higher scores are associated with more hazardous use.

Secondary

MeasureTime frameDescription
Change in Center for Epidemiological Studies-Depression (CES-D) Scale Score From Baseline to 6-month Post-baseline.Baseline and 6 months post-baselineCES-D is a 20-item scale of depression with a possible range of 0-60 (total scale score). Higher scores are associated with greater depression symptom severity.
Change in Harvard Trauma Questionnaire (HTQ) Post-traumatic Stress Disorder (PTSD) Symptom Scale Score From Baseline to 6-month Post-baseline.Baseline and 6 months post-baselineThe HTQ is a 39-item PTSD symptom scale with possible range of 1-4 (average scale score). Higher scores are associated with greater PTSD symptom severity.
Number of Participants With Any Recent Substance Use.6 months post-baselineAny recent substance use will be defined as any use of the following substance types in the past 3 months: inhalants, marijuana, cocaine, amphetamines, sedatives, hallucinogens, opioids.

Countries

Zambia

Participant flow

Participants by arm

ArmCount
Brief Intervention (BI)
30 minute alcohol brief intervention delivered by lay provider during HIV clinic visit. Brief Intervention: The BI used in the trial combines motivational interviewing skills with cognitive behavioral therapy elements in order to assist clients with self identified substance misuse to begin to consider changing their rates of drinking and drug use. The intervention lasts 30 to 40 minutes and consists of 5 components including: 1) screening 2) identification and information on the impacts of substance misuse 3) talking about change and goal setting 4) understanding the primary reason for drinking 5) skill building with practice and 6) referral for services.
78
Brief Intervention + CETA
30 minute alcohol brief intervention delivered by lay provider during clinic visit followed by 6-12 weekly sessions of CETA. Brief Intervention: The BI used in the trial combines motivational interviewing skills with cognitive behavioral therapy elements in order to assist clients with self identified substance misuse to begin to consider changing their rates of drinking and drug use. The intervention lasts 30 to 40 minutes and consists of 5 components including: 1) screening 2) identification and information on the impacts of substance misuse 3) talking about change and goal setting 4) understanding the primary reason for drinking 5) skill building with practice and 6) referral for services. Common Elements Treatment Approach (CETA): The Common Elements Treatment Approach, or CETA, is a transdiagnostic psychotherapy based on cognitive behavioral elements for mood, anxiety and trauma related problems, and for alcohol and substance misuse. CETA is based on the fact that most evidence-based mental health treatments (EBTs) consist of similar components. The objective of CETA is to provide a single training in a range of therapy components that are similar across EBTs and to then teach counselors how to design a specific course of treatment for each client based on the client's presenting problems.
82
Total160

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath10
Overall StudyLost to Follow-up12
Overall StudyMoved from study area.02
Overall StudyNot post-assessed. Study ended early due to COVID-192016

Baseline characteristics

CharacteristicBrief Intervention (BI)TotalBrief Intervention + CETA
Age, Continuous41.8 Years
STANDARD_DEVIATION 9
40.2 Years
STANDARD_DEVIATION 9.3
38.6 Years
STANDARD_DEVIATION 9.4
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
78 Participants160 Participants82 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants
Region of Enrollment
Zambia
78 participants160 participants82 participants
Sex: Female, Male
Female
34 Participants70 Participants36 Participants
Sex: Female, Male
Male
44 Participants90 Participants46 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
1 / 780 / 82
other
Total, other adverse events
0 / 780 / 82
serious
Total, serious adverse events
1 / 780 / 82

Outcome results

Primary

Change in Alcohol Use Disorders Identification Test (AUDIT) Scale Score From Baseline to 6-month Post-baseline.

AUDIT is a 10-item measure of hazardous alcohol use with possible range of 0-40 (total scale score). Higher scores are associated with more hazardous use.

Time frame: Baseline and 6 months post-baseline

Population: Analysis conducted only among participants with complete data at 6-month follow-up, which include 56 completers out of 78 participants in BI group and 62 completers out of 82 participants in BI + CETA group.

ArmMeasureValue (MEAN)
Brief Intervention (BI)Change in Alcohol Use Disorders Identification Test (AUDIT) Scale Score From Baseline to 6-month Post-baseline.-10.5 Score on a scale
Brief Intervention + CETAChange in Alcohol Use Disorders Identification Test (AUDIT) Scale Score From Baseline to 6-month Post-baseline.-13.7 Score on a scale
Secondary

Change in Center for Epidemiological Studies-Depression (CES-D) Scale Score From Baseline to 6-month Post-baseline.

CES-D is a 20-item scale of depression with a possible range of 0-60 (total scale score). Higher scores are associated with greater depression symptom severity.

Time frame: Baseline and 6 months post-baseline

Population: Analysis conducted only among participants with complete data at 6-month follow-up, which include 56 completers out of 78 participants in BI group and 62 completers out of 82 participants in BI + CETA group.

ArmMeasureValue (MEAN)
Brief Intervention (BI)Change in Center for Epidemiological Studies-Depression (CES-D) Scale Score From Baseline to 6-month Post-baseline.-4.2 Score on a scale
Brief Intervention + CETAChange in Center for Epidemiological Studies-Depression (CES-D) Scale Score From Baseline to 6-month Post-baseline.-8.9 Score on a scale
Secondary

Change in Harvard Trauma Questionnaire (HTQ) Post-traumatic Stress Disorder (PTSD) Symptom Scale Score From Baseline to 6-month Post-baseline.

The HTQ is a 39-item PTSD symptom scale with possible range of 1-4 (average scale score). Higher scores are associated with greater PTSD symptom severity.

Time frame: Baseline and 6 months post-baseline

Population: Analysis conducted only among participants with complete data at 6-month follow-up, which include 56 completers out of 78 participants in BI group and 62 completers out of 82 participants in BI + CETA group.

ArmMeasureValue (MEAN)
Brief Intervention (BI)Change in Harvard Trauma Questionnaire (HTQ) Post-traumatic Stress Disorder (PTSD) Symptom Scale Score From Baseline to 6-month Post-baseline.-0.3 Score on a scale
Brief Intervention + CETAChange in Harvard Trauma Questionnaire (HTQ) Post-traumatic Stress Disorder (PTSD) Symptom Scale Score From Baseline to 6-month Post-baseline.-0.5 Score on a scale
Secondary

Number of Participants With Any Recent Substance Use.

Any recent substance use will be defined as any use of the following substance types in the past 3 months: inhalants, marijuana, cocaine, amphetamines, sedatives, hallucinogens, opioids.

Time frame: 6 months post-baseline

Population: Analysis conducted only among participants with complete data at 6-month follow-up, which include 56 completers out of 78 participants in BI group and 62 completers out of 82 participants in BI + CETA group.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Brief Intervention (BI)Number of Participants With Any Recent Substance Use.14 Participants
Brief Intervention + CETANumber of Participants With Any Recent Substance Use.16 Participants

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026